Aerobic exercise does not predict brain derived neurotrophic factor and cortisol alterations in depressed patients

CNS and Neurological Disorders - Drug Targets

Volumn 14, Issue 9, 2015, Pages 1116-1128

  Lamego, Murilo Khede ^a   De Souza Moura, Antonio Marcos ^a   Paes, Flávia ^a   Rocha, Nuno Barbosa Ferreira ^b   De Sá Filho, Alberto Souza ^a   Lattari, Eduardo ^a   Rimes, Ridson ^a   Manochio, João ^a   Budde, Henning ^c   Wegner, Mirko ^d   Mura, Gioia ^e   Arias Carrión, Oscar ^f,g   Yuan, Ti Fei ^h   Nardi, Antonio Egidio ^a   Machado, Sergio ^a,i  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^c Asklepios Medical School Hamburg   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF CAGLIARI   (Italy)

^f HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^g HOSPITAL GENERAL DE MÉXICO   (Mexico)

^h NANJING NORMAL UNIVERSITY   (China)

ⁱ SALGADO DE OLIVEIRA UNIVERSITY   (Brazil)

Author keywords

Aerobic exercise; Biomarkers; Brain derived neurotrophic factor; Cognition; Cortisol; Depression

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GROWTH HORMONE; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; PROLACTIN; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

AEROBIC EXERCISE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ASSESSMENT; CYCLOERGOMETER TEST; DEPRESSION; DIAGNOSTIC TEST; ENERGY EXPENDITURE; GENETIC VARIABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIPID OXIDATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; PROTEIN EXPRESSION; SYNAPTIC TRANSMISSION; TREADMILL TEST; ANIMAL; BLOOD; EXERCISE; PHYSIOLOGY;

ANIMALS; BIOMARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER; EXERCISE; HUMANS; HYDROCORTISONE;

EID: 84959492787     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527315666151111125402     Document Type: Article

References (157)

1. Baune B. Conceptual challenges of a tentative model of stressinduced depression. PLoS One 2009; 4 (1): 42-66.
2. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65(9): 732-41.
3. Guilloux JP, Douillard-Guilloux G, Kota R, et al. Molecular evidence for BDNF and GABA related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry 2012; 17(11): 1130-42.
4. Sen S, Duman R, Sanacora G. Serum Brain Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta- Analyses and Implications. Biol Psychiatry 2008; 64: 527-32.
5. Duman R, Monteggia LM. A Neurotrophic Model for Stress Related Mood Disorders. Biol Psychiatry 2006; 59: 1116-27.
6. Naert G, Ixart G, Maurice T, Tapia-Arancibia L, Givalois L. Brain derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive like state induced by chronic restraint stress. Mol Cell Neurosci 2011; 46: 55-66.
7. Binder DK, Scharfman HE. Brain derived Neurotrophic Factor. Growth Fact 2004; 22(3): 123-31.
8. Rajkowska G. Histopatology of the pre-frontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits? Prog Brain Res 2000; 126: 397-412.
9. Bowley MP, Drevets WC, Ongur D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002; 52: 404-12.
10. Hamidi M, Drevets WC, Price JL. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry 2004; 55: 563-9.
11. Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 2004; 16: 1957-66.
12. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a metaanalysis. Am J Psychiatry 2004; 161: 598-607.
13. Castrén E, Võikar V, Rantamaki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007; 7: 18-21.
14. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-8.
15. Molendijk ML, Bus BA, Spinhoven P, et al. Serum levels of Brain derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 2011; 16(11): 1088-95.
16. Hasler G. Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 2010; 9: 155-61.
17. Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS. Cortisol secretion in endogenous depression in basal plasma levels. Arch Gen Psychiatry 1985; 42: 904-8.
18. Stokes PE, Stoll PM, Koslow SH, et al. Pre treatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups: a multicenter study. Arch Gen Psychiatry 1984; 41: 257-67.
19. Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK. Serial assessment of corticotrophin-releasing hormone response after dexamethasone in depression: implications for pathophysiology of DST non suppression. Biol Psychiatry 1987; 22: 228-34.
20. Holsboer F, Lauer CJ, Schreiber W, Krieg JC. Altered hypothalamic pituitary- adrenocortical regulation in health subjects at high familial risk for affective disorders. Neuroendocrinol 1995; 62: 340-7.
21. Ida M, Ida E, Wada N, Sohmiya M, Tazawa M, Shirakura K. A clinical study of the efficacy of a single session of individual exercise for depressive patients, assessed by the change in saliva free cortisol level. Biopsychosoc Med 2013; 7(1): 18.
22. Kennard BD, Silva SG, Tonev S, et al. Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry 2009; 48: 186-95.
23. Carek PJ, Laibstain SE, Carek SM. Exercise for the treatment of depression and anxiety. Int J Psychiatry Med 2011; 41(1): 15-28.
24. Eyre H, Baune B. Neuroimmunological Effects of Physical Exercise in Depression. Brain Behav Immun 2012; 26 (2): 251-66.
25. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst Rev 2008; 8(4): CD004366.
26. Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 2007; 69(7): 587-96.
27. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health: A recommendation from the centers for disease control and prevention and the American College of Sports Medicine. JAMA 1995; 273: 402-7.
28. Froelicher VF. Exercise, fitness, and coronary heart disease. In: Exercise, fitness, and health. Bouchard C, Shepard RJ, Stephens T, et al.: Eds.; Human Kinetics: Champaign 1990: pp. 429-50.
29. Chaouloff F, Elghozi JL, Guezennec Y, Laude D. Effects of conditioned running on plasma, liver and Brain tryptophan and on Brain 5-hydroxytryptamine metabolism of the rat. Br J Pharmacol 1985; 86 (1): 33-41.
30. Droste SK, Gesing A, Ulbritch S, Reul JM. Effects of long-term voluntary exercise on the mouse hypothalamic-pituitaryadrenocortical axis. Endocrinology 2003; 144 (7): 3012-7.
31. Garcia, C, Chen MJ, Garza AA, et al. The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience 2003; 119(3): 721-32.
32. Nabkasorn C, Miyai N, Sootmongkol A, et al. Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms. Eur J of Public Health 2005; 16(2): 179-84.
33. Van der Borght K, Kobor-Nyakas DE, Klauke K, et al. Physical exercise leads to rapid adaptations in hippocampal vasculature: temporal dynamics and relationship to cell proliferation and neurogenesis. Hippocampus 2009; 19(10): 928-36.
34. Christiansen T, Paulsen SK, Brunn JM, Pedersen SB, Richelsen B. Exercise training versus diet-induced weight-loss metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. Am Physiol Endocrionol Metab 2010; 298(4): 824-31.
35. Donges CE, Duffield R, Drinkwater EJ. Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition. Med Sci Sports Exerc 2010; 42(2): 304-13.
36. Mata J, Thompson RJ, Jaeggi SM, Buschkuehl M, Jonides J, Gotlib IH. Walk on the bright side: Physical activity and affect in major depressive disorder. J Abnorm Psychol 2012; 121(2): 297-308.
37. Rethorst CD, Landers DM, Nagoshi CT, Ross JT. The Efficacy of exercise in reducing depressive symptoms across 5-HTTLPR Genotypes. Med Sci Sports Exerc 2010; 42(11): 2141-7.
38. Sousa e Silva T, Longui CA, Rocha MN, et al. Prolonged Physical Training Decreases Mrna Levels of Glucocorticoid Receptor and Inflammatory Genes. Horm Res Paediatr 2010; 74(1): 6-14.
39. Pedersen BK. The diseasome of physical inactivity-and the role of myokines in muscle-fat cross talk. J Physiol 2009; 587: 5559-68.
40. Pedersen BK, Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol 2009; 107: 1006-14.
41. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006; 16(1): 3-63.
42. Laughlin MH, Roseguini B. Mechanisms for exercise traininginduced increases in skeletal muscle blood flow capacity: differences with interval sprint training versus aerobic endurance training. J Physiol Pharmacol 2008; 59(7): 71-88.
43. Kramer AF, Hahn S, Cohen NJ, et al. Ageing, fitness and neurocognitive function. Nature 1999; 400(6743): 418-9.
44. Berchtold NC, Castello N, Cotman CW. Exercise and time dependent benefits to learning and memory. Neuroscience 2010; 167: 588-97.
45. Cotman CW, Berchtold NC, Adlard PA, et al. Exercise and the brain. In: Molecural and Cellular Exercise Physiology. Mooren FC, Völker K, Eds.; Campaign, USA, Human Kinetics 2005; pp. 331-41.
46. Barde YA. Then nerve growth factor family. Prog Growth Factor Res 1990; (2): 237-48.
47. Kruttgen A, Schneider I, Weis J. The dark side of the NGF family: Neurotrophins in Neoplasias. Brain Pathol 2006; 16(4): 304-10.
48. Reichardt LF. Neurotrophin regulated signalling pathways Philos Trans R Soc Lond B Biol Sci 2006; 361(1473): 1545-64.
49. Vicario-Abejón C, Owens D, McKay R, Segal M. Role of neurotrophins in central synapse formation and stabilization. Nat Rev Neurosci 2002; 3: 965-74.
50. Hennigan A, O’Callaghan RM, Kelly AM. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem Soc Trans 2007; 35: 424-7.
51. Vaynman S, Gomez-Pinilla F. License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophin. Neurorehab Neur Repair 2005; 19(4): 283-94.
52. Bibel M, Barde Y. Neurotrophins: key regulator of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000; 14(23): 2919-37.
53. Lee FS, Kim AH, Khursigara G. The uniqueness of being a neurotrophin receptor. Curr Opin Neurobiol 2001; 11 (3): 281-6.
54. Nieto R, Kukulja M, Silva H. BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory. Front Psychiatry 2013; 17(4): 45.
55. Seidah NG, Benjannet S, Pareek S, Chrétien M, Murphy RA. Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett 1996; 379: 247-50.
56. Frade JM, Rodriguez-Tebar A, Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996; 383(6596): 166-8.
57. Zagrebelsky M, Holz A, Dechant G, Barde YA, Bonhoeffer T, Korte M. The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J Neurosci 2005; 25(43): 9989-99.
58. Rosch H, Schweigreiter R, Bonhoeffer T, Barde YA, Korte M. The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus. Proc Natl Acad Sci USA 2005; 102(20): 7362-7.
59. Woo NH, Teng HK, Siao CJ, et al. Activation of p75NTR by pro BDNF facilitates hippocampal long-term depression. Nat Neurosci 2005; 8(8): 1069-77.
60. Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci 2005; 6: 603-14.
61. Dwivedi Y. Brain-Derived Neurotrophic Factor: role in depression and suicide. Neuropsychiatry Dis Treat 2009; 5: 433-49.
62. Knaepen K, Goekint M, Heyman EM, Meeusen R. Neuroplasticity -Exercise-Induced Response of Peripheral Brain-Derived Neurotrophic Factor. Sports Med 2010; 40(9): 765-801.
63. Lom B, Cohen-Cory S. Brain-Derived Neurotrophic Factor Differentially Regulates Retinal Ganglion Cell Dendritic and Axonal Arborization In Vivo. J Neurosci 1999; 19(22): 9928-38.
64. McAllister AK, Katz LC, Lo DC. Neurotrophins and synaptic plasticity. Annu Rev Neurosci 1999; 22: 295-318.
65. Yacoubian TA, Lo DC. Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth. Nat Neurosci 2000; 3(4): 342-9.
66. Lyons WE, Mamounas LA, Ricaurte GA, et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 1999; 96(26): 15239-44.
67. Tonra JR, Ono M, Liu X, et al. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr (db)/lepr (db) mice. Diabetes 1999; 48(3): 588-94.
68. Tsuchida A, Nonomura T, Ono-Kishino M, Nakagawa T, Taiji M, Noguchi H. Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int J Obes Relat Metab Disord 2001; 25(9): 1286-93.
69. Wu A, Ying Z, Gomez-Pinilla F. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci 2004; 19(7): 1699-707.
70. Barde YA. Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res 1994; 390: 45-56.
71. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002; 25(6): 295-301.
72. Gomez-Pinilla F, Vanyman S, Ying Z. Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition. Eur J Neurosci 2008; 28: 2278-87.
73. Gray J, Yeo GS, Cox JJ, et al. Hyperphagia, severe obesity, impaired cognitive function, and hyper reactivity associated with functional loss of one copy of the brain derived neurotrophic factor (BDNF) gene. Diabetes 2006; 55(12): 3366-71.
74. Araya AV, Orellana X, Espinoza J. Evaluation of the effect of caloric restriction on serum BDNF in overweight and obese subjects: preliminary evidences. Endocrine 2008; 33(3): 300-4.
75. Pedersen BK, Pedersen M, Krabbe KS, Bruunsgaard H, Matthews VB, Febbraio MA. Role of exercise induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals. Exp Physiol 2009; 94(12): 1153-60.
76. Wisse BE, Schwartz MW. The skinny on neurotrophins. Nat Neurosci 2003; 6(7): 655-6.
77. Hall JE. Guyton and Hall Textbook of Medical Physiology. 12th ed. Elsevier 2010.
78. Rosenfeld P, van Eekelen JA, Levine S, et al. Ontogeny of corticosteroid receptors in the brain. Cell Mol Neurobiol 1993; 13: 295-319.
79. Joels M, de Kloet ER. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Progress Neurobiol 1994; 43: 1-36.
80. Gutierrez-Mecinas M, Trollope AF, Collins A, et al. Long-lasting behavioral responses to stress involve a direct interaction of glucocorticoid receptors with ERK1/2-MSK1-Elk-1 signaling. Proc Natl Acad Sci USA 2011; 108: 13806-11.
81. Kirschbaum C, Hellhammer D. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinol 1994; 19: 313-33.
82. Hucklebridge F, Clow A, Evans P. The relationship between salivary secretory immunoglobulin A and cortisol: neuroendocrine response to awakening and the diurnal cycle. Int J Psychophysiol 1998; 31: 69-76.
83. de Kloet ER, Derijk RH, Meijer OC. Therapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? Nat Clin Pract Endocrinol Metab 2007; 3: 168-79.
84. Knorr U, Vinberg M, Kessing LV, Wetterslev J. Salivary cortisol in depressed patients versus control persons: A systematic review and meta-analysis. Psychoneuroendocrinology 2010; 35: 1275-86.
85. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23(5): 477-501.
86. Ising M, Horstmann S, Kloiber S, et al. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression a potential biomarker? Biol Psychiatry 2007; 62: 47-54.
87. Herbert J. Cortisol and depression: three questions for psychiatry. Psychol Med 2013; 43: 449-69.
88. Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 1973; 28: 19-24.
89. Carroll BJ, Martin FI, Davies B. Resistance to suppression by dexamethasone of plasma 11-O.H.C.S.levels in severe depressive illness. Br Med J 1968; 3: 285-7.
90. Carroll BJ. Use of the dexamethasone suppression test in depression. J Clin Psychiatry 1982; 43: 44-50.
91. Butler PW, Besser GM. Pituitary-adrenal function in depression. Lancet 1968; 2: 51.
92. Jeffcoate WJ, Silverstone JT, Edwards CR, Besser GM. Psychiatric manifestations of Cushing’s syndrome: response to lowering of plasma cortisol. Q J Med 1979; 48: 465-72.
93. Lewis DA, Smith R. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 1983; 5: 319-32.
94. Portella MJ, Harmer CJ, Flint J, Cowen P, Goodwin GM. Enhanced early morning salivary cortisol in neuroticism. Am J Psychiatry 2005; 162: 807-9.
95. Goodyer IM, Herbert J, Tamplin A, Altham PM. Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br J Psychiatry 2000; 177: 499-504.
96. Harris TO, Borsanyi S, Messari S, et al. Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br J Psychiatry 2000; 177: 505-10.
97. Masters JN, Finch CE, Sapolsky RM. Glucocorticoid endangerment of hippocampal neurons does not involve deoxyribonucleic acid cleavage. Endocrinology 1989; 124: 3083-8.
98. Tombaugh GC, Yang SH, Swanson RA, Sapolsky RM. Glucocorticoids exacerbate hypoxic and hypoglycemic hippocampal injury in vitro: biochemical correlates and a role for astrocytes. J Neurochem 1992; 59: 137-46.
99. Parker GB, Brown LB. Coping behaviors that mediate between life events and depression. Arch Gen Psychiatry 1982; 39: 1386-91.
100. Kendler KS, Kuhn JW, Prescott CA. Childhood sexual abuse, stressful life events and risk for major depression in women. Psychol Med 2004; 34: 1475-82.
101. Gubba EM, Netherton CM, Herbert J. Endangerment of the brain by glucocorticoids: experimental and clinical evidence. J Neurocytol 2000; 29: 439-49.
102. Nibuya M, Takahashi M, Russell DS, Duman RS. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 1999; 267: 81-4.
103. Kalueff AV, Gallagher PS, Murphy DL. Are serotonin transporter knockout mice depressed? Hypoactivity but no anhedonia. Neuroreport 2006; 17: 1347-51.
104. Ringstedt T, Linnarsson S, Wagner J, et al. BDNF regulates reelin expression and Cajal- Retzius cell development in the cerebral cortex. Neuron 1998; 21: 305-15.
105. Hartmann M, Heumann R, Lesmann V. Synaptic secretion of BDNF after high-frequency stimulation of glutaminergic synapses. EMBO J 2001; 20: 5877-97.
106. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004; 26: 137-46.
107. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain derived neurotrophic factor (BDNF) in depressed patients with or without antidepressant. Biol Psychiatry 2003; 54: 70-5.
108. Castren E, Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol 2010; 70(5): 289-97.
109. Krogh J, Nordentoft M, Mohammad-Nezhad M, Westrin A. Growth hormone, prolactin and cortisol response to exercise in patients with depression. J Affect Disord 2010; 125: 189-97.
110. Garcia FD, Coquerel Q, Kiive E, Déchelotte P, Harro J, Fetissov SO. Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 118-25.
111. Wied CCG, Jansen LMC, Jan HM, Thijssen JH, van Engeland H. Pituitary–adrenal function in adolescent psychiatric patients: impact of depressive symptoms. J Affect Disord 2000; 59: 71-6.
112. Kiive E, Maaroos J, Shlik J, Tõru I, Harro J. Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1007-13.
113. Gustafsson G, Lira CM, Johansson J, et al. The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder. Psychiatry Res 2009; 169(3): 244-48.
114. Laske C, Banschbach S, Stransky E, et al. Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int J Neuropsychopharmacol 2010; 13: 595-602.
115. Toups MSP, Greer TL, Kurian BT, et al. Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression. J Psychiatry Res 2011; 45: 1301-6.
116. Salehi I, Hosseini SM, Haghighi M, et al. Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder. J Psychiatr Res 2014; 57: 117-24.
117. Schuch FB, Vasconcelos-Moreno MP, Borowsky C, et al. The effects of exercise on oxidative stress (TBARS) and BDNF in severely depressed inpatients. Eur Arch Psychiatry Clin Neurosci 2014; 264(7): 605-13.
118. Aydemir O, Deveci A, Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29(2): 261-5.
119. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57(9): 1068-72.
120. Zoladz JA, Pilc A, Majerczak J, Grandys M, Zapart-Bukowska J, Duda K. Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men. J Physiol Pharmacol 2008; 59(17): 119-32.
121. Hunsberger JG, Newton SS, Bennett AH, et al. Antidepressant actions of the exercise-regulated gene VGF. Nat Med 2007; 13(12): 1476-82.
122. Gordon R, Spector S, Sjoerdsma A, Udenfriend S. Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold. J Pharmacol Exp Ther 1966; 153(3): 440-7.
123. Rudolph DL, McAuley E. Cortisol and affective responses to exercise. J Sports Sci 1998; 16(2): 121-8.
124. Luger A, Deuster PA, Kyle SB, et al. Acute hypothalamicpituitary- adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med 1987; 316(21): 1309-15.
125. Maniam J, Morris MJ. Voluntary exercise and palatable high-fat diet both improve behavioural profile and stress responses in male rats exposed to early life stress: role of hippocampus. Psychoneuroendocrinology 2010; 35(10): 1553-64.
126. Duclos M, Gouarne C, Bonnemaison D. Acute and chronic effects of exercise on tissue sensitivity to glucocorticoids. J Appl Physiol 2003; 94(3): 869-75.
127. Carro E, Nuñez A, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci 2000; 20(8): 2926-33.
128. Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007; 30(9): 464-72.
129. Ernst C, Olson AK, Pinel JP, Lam RW, Christie BR. Antidepressant effects of exercise: evidence for an adultneurogenesis hypothesis? J Psychiatry Neurosci 2006; 31(2): 84-92.
130. Asano M, Kaneoka K, Nomura T, et al. Increase in serum vascular endothelial growth factor levels during altitude training. Acta Physiol Scand 1998; 162(4): 455-9.
131. Marais L, Stein DJ, Daniels WM. Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats. Metab Brain Dis 2009; 24(4): 587-97.
132. Kari HP, Davidson PP, Kohl HH, Kochhar MM. Effects of ketamine on brain monoamine levels in rats. Res Commun Chem Pathol Pharmacol 1978; 20(3): 475-88.
133. Romanowski W, Grabiec S. The role of serotonin in the mechanism of central fatigue. Acta Physiol Pol 1974; 25(2): 127-34.
134. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989; 46(7): 587-99.
135. Meltzer H. Serotonergic dysfunction in depression. Br J Psychiatry Suppl 1989; 8: 25-31.
136. Acworth I, Nicholass J, Morgan B, Newsholme EA. Effect of sustained exercise on concentrations of plasma aromatic and branched-chain amino acids and brain amines. Biochem Biophys Res Commun 1986; 137(1): 149-53.
137. Greenwood BN, Strong PV, Loughridge AB, et al. 5-HT2C receptors in the basolateral amygdala and dorsal striatum are a novel target for the anxiolytic and antidepressant effects of exercise. PLoS One 2012; 7(9): 46-118.
138. Lupien SJ, Buss C, Schramek TE, Maheu F, Pruessner J. Hormetic influence of glucocorticoids on human memory. Non linearity Biol Toxicol Med 2005; 3(1): 23-56.
139. Wust S, Federenko I, Hellhammer DH, Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000; 25(7): 707-20.
140. Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav 2003; 43(1): 60-6.
141. Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 1987; 44(4): 328-36.
142. Droste SK, Chandramohan Y, Hill LE, Linthorst AC, Reul JM. Voluntary exercise impacts on the rat hypothalamic-pituitaryadrenocortical axis mainly at the adrenal level.Neuroendocrinology 2007; 86(1): 26-37.
143. Budde H, Voelcker-Rehage C, Pietrassyk-Kendziorra S, Machado S, Ribeiro P, Arafat AM. Steroid hormones in the saliva of adolescents after different exercise intensities and their influence on working memory in a school setting. Psychoneuroendocrinology 2010; 35(3): 382-91.
144. Mathur DN, Toriola AL, Dada OA. Serum cortisol and testosterone levels in conditioned male distance runners and nonathletes after maximal exercise. J Sports Med Phys Fitness 1986; 26(3): 245-50.
145. Leuner B, Gould E, Shors TJ. Is there a link between adult neurogenesis and learning? Hippocampus 2006; 16(3): 216-24.
146. Winocur G, Wojtowicz JM, Sekeres M, et al. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 2006; 16(3): 296-304.
147. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain.Physiol Rev 2007; 87(3): 873-904.
148. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997; 20(2): 78-84.
149. Bremner JD, Narayan M, Anderson ER, et al. Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157(1): 115-8.
150. van Praag H, Kempermann G, Gage FH. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci 1999; 2(3): 266-70.
151. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15(11); 7539-47.
152. Barbany G, Persson H. Regulation of Neurotrophin mRNA Expression in the Rat Brain by Glucocorticoids. Eur J Neurosci 1992; 4(5): 396-403.
153. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002: 71(3): 651-5.
154. Duman CH, Schlesinger L, Russell DS, Duman RS. Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res 2008; 1199: 148-58.
155. Ströhle A, Stoy M, Graetz B, et al. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology 2012; 35(3): 364-8.
156. Schobersberger W, Hobisch-Hagen P, Fries D. et al. Increase in immune activation, vascular endothelial growth factor and erythropoietin after an ultramarathon run at moderate altitude. Immunology 2000; 201(5): 611-20.
157. Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 1996; 81(10): 3492-7.